Conception of National Biologics Registry for Pediatric Rheumatology: Need of the Hour and the Way Forward

The outcome for children with rheumatic diseases has been dramatically altered by the use of biological therapies. Increasing use of these agents will need careful monitoring for long term safety, particularly in children. Current data on safety of these drugs stem exclusively from Western literatur...

Descripción completa

Detalles Bibliográficos
Autores principales: Bagri, Narendra Kumar, Kumar, Sathish, Ramanan, Athimalaipet V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798937/
https://www.ncbi.nlm.nih.gov/pubmed/36089846
http://dx.doi.org/10.1007/s13312-022-2661-8
_version_ 1784861009275518976
author Bagri, Narendra Kumar
Kumar, Sathish
Ramanan, Athimalaipet V.
author_facet Bagri, Narendra Kumar
Kumar, Sathish
Ramanan, Athimalaipet V.
author_sort Bagri, Narendra Kumar
collection PubMed
description The outcome for children with rheumatic diseases has been dramatically altered by the use of biological therapies. Increasing use of these agents will need careful monitoring for long term safety, particularly in children. Current data on safety of these drugs stem exclusively from Western literature. There is clear need for a registry of all children with rheumatic diseases who are commenced on biological agents to ensure appropriate pharmacovigilance. In this perspective, we discuss the need for and the role of a biologics registry for children with rheumatic diseases in India.
format Online
Article
Text
id pubmed-9798937
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer India
record_format MEDLINE/PubMed
spelling pubmed-97989372022-12-30 Conception of National Biologics Registry for Pediatric Rheumatology: Need of the Hour and the Way Forward Bagri, Narendra Kumar Kumar, Sathish Ramanan, Athimalaipet V. Indian Pediatr Perspective The outcome for children with rheumatic diseases has been dramatically altered by the use of biological therapies. Increasing use of these agents will need careful monitoring for long term safety, particularly in children. Current data on safety of these drugs stem exclusively from Western literature. There is clear need for a registry of all children with rheumatic diseases who are commenced on biological agents to ensure appropriate pharmacovigilance. In this perspective, we discuss the need for and the role of a biologics registry for children with rheumatic diseases in India. Springer India 2022-09-09 2022 /pmc/articles/PMC9798937/ /pubmed/36089846 http://dx.doi.org/10.1007/s13312-022-2661-8 Text en © Indian Academy of Pediatrics 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Perspective
Bagri, Narendra Kumar
Kumar, Sathish
Ramanan, Athimalaipet V.
Conception of National Biologics Registry for Pediatric Rheumatology: Need of the Hour and the Way Forward
title Conception of National Biologics Registry for Pediatric Rheumatology: Need of the Hour and the Way Forward
title_full Conception of National Biologics Registry for Pediatric Rheumatology: Need of the Hour and the Way Forward
title_fullStr Conception of National Biologics Registry for Pediatric Rheumatology: Need of the Hour and the Way Forward
title_full_unstemmed Conception of National Biologics Registry for Pediatric Rheumatology: Need of the Hour and the Way Forward
title_short Conception of National Biologics Registry for Pediatric Rheumatology: Need of the Hour and the Way Forward
title_sort conception of national biologics registry for pediatric rheumatology: need of the hour and the way forward
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798937/
https://www.ncbi.nlm.nih.gov/pubmed/36089846
http://dx.doi.org/10.1007/s13312-022-2661-8
work_keys_str_mv AT bagrinarendrakumar conceptionofnationalbiologicsregistryforpediatricrheumatologyneedofthehourandthewayforward
AT kumarsathish conceptionofnationalbiologicsregistryforpediatricrheumatologyneedofthehourandthewayforward
AT ramananathimalaipetv conceptionofnationalbiologicsregistryforpediatricrheumatologyneedofthehourandthewayforward

Ejemplares similares